Norman Wolmark, MD
Director of Oncology, West Penn Allegheny Health System
Norman Wolmark, MD, has served as Group Chair of the National
Surgical Adjuvant Breast and Bowel Project (NSABP) since 1994. Dr Wolmark is
also the professor and chairman at Drexel University School of Medicine and
Chair Department of Human Oncology at Allegheny General Hospital.
A cancer researcher since the early 1970s, Dr Wolmark has
authored or co-authored more than 190 articles in peer-reviewed journals. His
current research efforts are devoted to the evolution of large randomized
prospective clinical trials for the treatment and prevention of breast and
bowel cancer, including the NSABP’s 1998 Breast Cancer Prevention Trial of
tamoxifen in reducing the incidence of breast cancer.
Dr Wolmark holds membership with several professional and
scientific societies including the Royal College of Surgeons (Canada), the
American College of Surgeons, the American Surgical Association, the American
Association for Cancer Research, the American Society of Clinical Oncology, the
Society of Surgical Oncology, the Society of University Surgeons, the Society
for Clinical Trials, the American Association for the Advancement of Science,
and the Association of American Cancer Institutes.
Following his internship and residency in surgery at McGill
University in Montreal and at the University of Pittsburgh, Dr Wolmark served
as a cancer expert at the Surgery Branch of the National Cancer Institute and
completed his postgraduate clinical training in surgical oncology at Memorial
Sloan-Kettering Cancer Center. In 1979 he returned to the University of
Pittsburgh as an assistant professor of Surgery and became the executive
medical officer of the NSABP. He was tenured in 1984 and was appointed the Mark
M. Ravitch Professor of Surgery at the University in 1989.